Glossary
The state-of-the-art glossary for Waldenström’s macroglobulinemia.
Bendamustine
Bendamustine in the glossary for Waldenström's macroglobulinemia
An alkylating agent (chemotherapy)
Bendamustine, is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma (MM), and non-Hodgkin's lymphoma (NHL).1 It is administered intravenously. Bendamustine belongs to the alkylating-agent family of anticancer agents. Its mechanism of action involves interfering with the function of DNA and RNA. Bendamustine is authorized for use in a number of European countries.2,3
Glossary overview